Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|September 25, 2020

Words of Solace in Dark Times

Author(s)Amilcar Arnaldo Tirado, MD, MBA

Dr Tirado offers words of wisdom and encouragement on the pandemic.

Amilcar Arnaldo Tirado, MD, MBA, shares his experience with fighting COVID-19 and expand on his recent article in Psychiatric Times: Surviving Coronavirus: A Psychiatrist’s Personal Journey. Dr Tirado is a forensic psychiatrist at Lincoln Medical Center in the Bronx, NY, and assistant clinical professor of psychiatry at Weill Cornell Medicine, New York, NY.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Jersey City Psychiatry

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Trending on Psychiatric Times

Kratom Component in Clinical Trial for Opioid Use Disorder

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

FDA Clears First and Only Single-Biomarker Blood Test for Alzheimer Disease Assessment

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder